A failed trial for a heart drug casts shadow over rivals developing similar therapies
The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.
This is a summary aggregated from MarketWatch. Read the complete article on the original site:
Read full article at MarketWatch
